Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("KLIJN, Jan")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 91

  • Page / 4
Export

Selection :

  • and

Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersKOTSOPOULOS, Joanne; LUBINSKI, Jan; DOMCHEK, Susan et al.Breast cancer research and treatment. 2007, Vol 105, Num 2, pp 221-228, issn 0167-6806, 8 p.Article

Pooled analysis of prognostic impact of uPA and PAI-I in breast cancer patientsLOOK, Maxime; VAN PUTTEN, Wim; SWEEP, C. G. J. Fred et al.Thrombosis and haemostasis. 2003, Vol 90, Num 3, pp 538-548, issn 0340-6245, 11 p.Article

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibilitySCHUTTE, Mieke; SEAL, Sheila; VAN DEN OUWELAND, Ans et al.American journal of human genetics. 2003, Vol 72, Num 4, pp 1023-1028, issn 0002-9297, 6 p.Article

A BRCA1/2 mutation, high breast density and prominent pushing margins of a tumor independently contribute to a frequent false-negative mammographyTILANUS-LINTHORST, Madeleine; VERHOOG, Leon; OBDEIJN, Inge-Marie et al.International journal of cancer. 2002, Vol 102, Num 1, pp 91-95, issn 0020-7136, 5 p.Article

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers : An international case-control studyEISEN, Andrea; LUBINSKI, Jan; FOULKES, William D et al.Journal of clinical oncology. 2005, Vol 23, Num 30, pp 7491-7496, issn 0732-183X, 6 p.Article

The CHEK2 1100DelC mutation identifies families with a hereditary breast and colorectal cancer phenotypeMEIJERS-HEIJBOER, Hanne; WIJNEN, Juul; BREKELMANS, Cecile et al.American journal of human genetics. 2003, Vol 72, Num 5, pp 1308-1314, issn 0002-9297, 7 p.Article

Optimization of tone-mapping functions in video cameras for high dynamic range imagesCVETKOVIC, Sascha D; KLIJN, Jan; DE WITH, Peter H. N et al.Proceedings of SPIE, the International Society for Optical Engineering. 2008, pp 68110Q.1-68110Q.7, issn 0277-786X, isbn 978-0-8194-6983-0, 1VolConference Paper

Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriersCULLINANE, Carey A; LUBINSKI, Jan; FRIEDMAN, Eitan et al.International journal of cancer. 2005, Vol 117, Num 6, pp 988-991, issn 0020-7136, 4 p.Article

Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriersNAROD, Steven A; DUBE, Marie-Pierre; OFFIT, Kenneth et al.Journal of the National Cancer Institute. 2002, Vol 94, Num 23, pp 1773-1779, issn 0027-8874, 7 p.Article

Smoking and the risk of breast cancer in BRCA1 and BRCA2 carriers : an updateGINSBURG, Ophira; GHADIRIAN, Parviz; KLIJN, Jan et al.Breast cancer research and treatment. 2009, Vol 114, Num 1, pp 127-135, issn 0167-6806, 9 p.Article

Hormone Therapy and the Risk of Breast Cancer in BRCA1 Mutation CarriersEISEN, Andrea; LUBINSKI, Jan; MANOUKIAN, Siranoush et al.Journal of the National Cancer Institute. 2008, Vol 100, Num 19, pp 1361-1367, issn 0027-8874, 7 p.Article

International variation in rates of uptake of preventive options in BRCA1 and BRCA2 mutation carriersMETCALFE, Kelly A; BIRENBAUM-CARMELI, Daphna; KIM-SING, Charmaine et al.International journal of cancer. 2008, Vol 122, Num 9, pp 2017-2022, issn 0020-7136, 6 p.Article

A multicenter study of cancer incidence in CHEK2 1100delC mutation carriersTHOMPSON, Deborah; SEAL, Sheila; KLIJN, Jan et al.Cancer epidemiology, biomarkers & prevention. 2006, Vol 15, Num 12, pp 2542-2545, issn 1055-9965, 4 p.Article

Progesterone antagonists and progesterone receptor modulators in the treatment of breast cancerKLIJN, Jan G. M; SETYONO-HAN, Buddy; FOEKENS, John A et al.Steroids. 2000, Vol 65, Num 10-11, pp 825-830, issn 0039-128XConference Paper

Differential effects of fibroblast growth factors on expression of genes of the plasminogen activator and insulin-like growth factor systems by human breast fibroblastsSIEUWERTS, Anieta M; MARTENS, John W. M; DORSSERS, Lambert C. J et al.Thrombosis and haemostasis. 2002, Vol 87, Num 4, pp 674-683, issn 0340-6245Article

The use of gemonic tools for the molecular understanding of breast cancer and to guide personalized medicineFOEKENS, John A; YIXIN WANG; MARTENS, John W. M et al.Drug discovery today. 2008, Vol 13, Num 11-12, pp 481-487, issn 1359-6446, 7 p.Article

Thirteen new p53 gene mutants identified among 41 human breast cancer cell linesWASIELEWSKI, Marijke; ELSTRODT, Fons; KLIJN, Jan G. M et al.Breast cancer research and treatment. 2006, Vol 99, Num 1, pp 97-101, issn 0167-6806, 5 p.Article

The prognostic value of polymorphonuclear leukocyte elastase in patients with primary breast cancerFOEKENS, John A; RIES, Christian; LOOK, Maxime P et al.Cancer research (Baltimore). 2003, Vol 63, Num 2, pp 337-341, issn 0008-5472, 5 p.Article

Thymidine kinase and thymidylate synthase in advanced breast cancer : Response to tamoxifen and chemotherapyFOEKENS, John A; ROMAIN, Sylvie; LOOK, Maxime P et al.Cancer research (Baltimore). 2001, Vol 61, Num 4, pp 1421-1425, issn 0008-5472Article

Association of rare MSH6 variants with familial breast cancerWASIELEWSKI, Marijke; RIAZ, Muhammad; SCHUTTE, Mieke et al.Breast cancer research and treatment. 2010, Vol 123, Num 2, pp 315-320, issn 0167-6806, 6 p.Article

CHEK2 1100deIC and male breast cancer in the NetherlandsWASIELEWSKI, Marijke; DEN BAKKER, Michael A; VAN DEN OUWELAND, Ans et al.Breast cancer research and treatment. 2009, Vol 116, Num 2, pp 397-400, issn 0167-6806, 4 p.Article

Roles of Radiotherapy and Chemotherapy in the Development of Contralateral Breast CancerHOONING, Maartje J; ALEMAN, Berthe M. P; HAUPTMANN, Michael et al.Journal of clinical oncology. 2008, Vol 26, Num 34, pp 5561-5568, issn 0732-183X, 8 p.Article

Decreased risk of stroke among 10-year survivors of breast cancerHOONING, Maartje J; DORRESTEIJN, Lucille D. A; ALEMAN, Berthe M. P et al.Journal of clinical oncology. 2006, Vol 24, Num 34, pp 5388-5394, issn 0732-183X, 7 p.Article

Excess risk for contralateral breast cancer in CHEK2*1100delC germline mutation carriersBROEKS, Annegien; DE WITTE, Lot; NOOIJEN, Anke et al.Breast cancer research and treatment. 2004, Vol 83, Num 1, pp 91-93, issn 0167-6806, 3 p.Article

CHEK2 1100delC Is a Susceptibility Allele for HNPCC-Related Colorectal CancerWASIELEWSKI, Marijke; VASEN, Hans; WIJNEN, Juul et al.Clinical cancer research (Print). 2008, Vol 14, Num 15, pp 4989-4994, issn 1078-0432, 6 p.Article

  • Page / 4